FDA calls for heartburn drug Zantac to be pulled from market immediately

The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday, April 1st, 2020.

CNN reports that the FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, pose a risk to public health. Read more on CNN.com.

For more information on Zantac and the contaminant NDMA, click here.